Suchergebnisse - "Claxton, David"

PubPharm (206)

41

Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

enthalten in: Stem cell reviews and reports | 2022

von Long, N. | Golla, U. | Sharma, A. | +1

42

Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications

enthalten in: Stem cell reviews | 2022

von Long, N. | Golla, U. | Sharma, A. | +1

43

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

enthalten in: The FASEB Journal | 2022

von Fisher‐Wellman, K. | Hagen, J. | Kassai, M. | +11

44

Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia

enthalten in: The FASEB Journal | 2022

von Khokhlatchev, A. | Sharma, A. | Deering, T. | +13

45

Interleukin‐4 treatment reduces leukemia burden in acute myeloid leukemia

enthalten in: The FASEB Journal | 2022

von Qian, F. | Arner, B. | Kelly, K. | +5

46

A novel clinically relevant graft‐versus‐leukemia model in humanized mice

enthalten in: Journal of leukocyte biology | 2022

von Jia, B. | Zhao, C. | Bayerl, M. | +11

47

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

enthalten in: Cancer | 2021

von Kantarjian, H. | Begna, K. | Altman, J. | +25

48

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

enthalten in: Annals of hematology | 2021

von Shah, N. | Rakszawski, K. | Nickolich, M. | +13

49

DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia

enthalten in: Cancers | 2021

von Golla, U. | Ehudin, M. | Annageldiyev, C. | +13

50

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

enthalten in: Annals of hematology | 2021

von Shah, N. | Rakszawski, K. | Nickolich, M. | +13